Your browser doesn't support javascript.
loading
Left anterior descending artery avoidance in patients receiving breast irradiation.
Vayntraub, Aleksander; Quinn, Thomas J; Thompson, Andrew B; Chen, Peter Y; Gustafson, Gregory S; Jawad, Maha S; Dilworth, Joshua T.
Afiliación
  • Vayntraub A; Department of Radiation Oncology, Beaumont Health System, Royal Oak, MI 48073, USA.
  • Quinn TJ; Department of Radiation Oncology, Beaumont Health System, Royal Oak, MI 48073, USA.
  • Thompson AB; Department of Radiation Oncology, Beaumont Health System, Royal Oak, MI 48073, USA.
  • Chen PY; Department of Radiation Oncology, Beaumont Health System, Royal Oak, MI 48073, USA.
  • Gustafson GS; Department of Radiation Oncology, Beaumont Health System, Royal Oak, MI 48073, USA.
  • Jawad MS; Department of Radiation Oncology, Beaumont Health System, Royal Oak, MI 48073, USA.
  • Dilworth JT; Department of Radiation Oncology, Beaumont Health System, Royal Oak, MI 48073, USA. Electronic address: Joshua.dilworth@beaumont.edu.
Med Dosim ; 46(1): 57-64, 2021.
Article en En | MEDLINE | ID: mdl-32878728
ABSTRACT

PURPOSE:

Dose to the left anterior descending artery (LAD) may be significant in patients receiving left-sided irradiation for breast cancer. We investigated if prospective contouring and avoidance of the LAD during treatment planning were associated with lower LAD dose. METHODS AND MATERIALS We reviewed dosimetric plans for 323 patients who received left whole breast or chest wall irradiation with or without internal mammary node (IMLN) coverage between 1/2014 and 1/2019 at a single institution. The LAD was contoured prospectively for 155 cases, and techniques were utilized to minimize LAD dose. Dose-volume-histograms from these patients were compared to those of 168 patients for whom the LAD was contoured retrospectively after treatment completion. EQD2 was calculated to account for fractionation differences.

RESULTS:

Compared to cases where the LAD was contoured retrospectively (n = 126), prospective LAD contouring (n = 124) was associated with lower unadjusted median max and mean LAD doses for 250 patients receiving whole-breast irradiation (WBI) without IMLN coverage 8.5 Gy vs 5.2 Gy (p < 0.0001) and 3.6 Gy vs 2.7 Gy (p < 0.0001), respectively. EQD2 median max and mean LAD doses were also lower with prospective LAD contouring 5.2 Gy vs 3.0 Gy (p < 0.0001) and 1.9 Gy vs 1.5 Gy (p < 0.0001), respectively. Compared to cases where the LAD was contoured retrospectively (n = 42), prospective LAD contouring (n = 31) was associated with lower max LAD doses for 73 patients with IMLN coverage 20.4 Gy vs 14.3 Gy (p = 0.042). There was a nonsignificant reduction in median mean LAD dose 6.2 Gy vs 6.1 Gy (p = 0.33). LAD doses were reduced while maintaining IMLN coverage (mean V90%Rx >90%).

CONCLUSIONS:

Prospective contouring and avoidance of the LAD were associated with lower max and mean LAD doses in patients receiving WBI and with lower max LAD doses in patients receiving IMLN treatment. Further reduction in LAD dose may require stricter optimization weighting or compromise in IMLN coverage.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Neoplasias de Mama Unilaterales Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Female / Humans Idioma: En Revista: Med Dosim Asunto de la revista: RADIOTERAPIA Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Neoplasias de Mama Unilaterales Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Female / Humans Idioma: En Revista: Med Dosim Asunto de la revista: RADIOTERAPIA Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos